The Generic Challenge: Understanding Patents, FDA and Pharmaceutical Life-Cycle Management - Softcover
Inhaltsangabe
The Generic Challenge is a must read for pharmaceutical executives and managers, and regulatory, legal, business development, R&D and strategic marketing professionals and anyone who has an interest in the future of the leading American pharmaceutical and biotechnology industries and the high value jobs they provide. It explains clearly and understandably the role of patents, FDA regulation of generic drugs and the Hatch Waxman Act on drug development today and how improvements in innovative drug products provide enhanced benefits to patients while extending the commercial lives of the drugs. There is simply no other book of its kind available on this important subject. Chapters 1-2 cover patents generally and patent enforcement and infringement Chapter 3 covers pharmaceutical, biological and medical device patents Chapters 4-5 cover FDA and drug product exclusivities Chapter 6 covers the Hatch Waxman Act and recent Medicare Act Amendments Chapter 7 puts it all together with Pharmaceutical Life-Cycle Management
Die Inhaltsangabe kann sich auf eine andere Ausgabe dieses Titels beziehen.
Reseña del editor
The Generic Challenge is a must read for pharmaceutical executives and managers, and regulatory, legal, business development, R&D and strategic marketing professionals and anyone who has an interest in the future of the leading American pharmaceutical and biotechnology industries and the high value jobs they provide. It explains clearly and understandably the role of patents, FDA regulation of generic drugs and the Hatch Waxman Act on drug development today and how improvements in innovative drug products provide enhanced benefits to patients while extending the commercial lives of the drugs. There is simply no other book of its kind available on this important subject. Chapters 1-2 cover patents generally and patent enforcement and infringement Chapter 3 covers pharmaceutical, biological and medical device patents Chapters 4-5 cover FDA and drug product exclusivities Chapter 6 covers the Hatch Waxman Act and recent Medicare Act Amendments Chapter 7 puts it all together with Pharmaceutical Life-Cycle Management
„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.
Weitere beliebte Ausgaben desselben Titels
Suchergebnisse für The Generic Challenge: Understanding Patents, FDA and...
Beispielbild für diese ISBN
The Generic Challenge: Understanding Patents, Fda And Pharmaceutical Life-cycle Management
Anbieter: Books From California, Simi Valley, CA, USA
Verkäuferbewertung 5 von 5 Sternen
paperback. Zustand: Good. Bestandsnummer des Verkäufers mon0003553641
Gebraucht kaufen
EUR 4,31
EUR 4,26 shipping
Versand innerhalb von USA
Versand innerhalb von USA
Anzahl: 1 verfügbar